Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
about
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in miceα-catenin. A tumor suppressor beyond adherens junctions.Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results.Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome.Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AMLTopography, clinical, and genomic correlates of 5q myeloid malignancies revisitedPretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcomeLipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner.Unraveling the molecular pathophysiology of myelodysplastic syndromes.Recurrent genetic defects on chromosome 5q in myeloid neoplasms.Histone methylation in myelodysplastic syndromes.Epigenetics of myelodysplastic syndromes.miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin.Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro.Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
P2860
Q28114815-338954DC-3D92-40C0-918A-AE452BB3B620Q34028517-F8255E38-6257-4A46-856E-7892E7DDFEA4Q34109454-928CAD0C-B112-4642-8F5F-5F1BCF43BB68Q34361640-D6521BE9-6637-4354-8C5D-D81E0921C97FQ34521462-E00FA88E-5C7F-4C47-9750-9E60E9D35FA5Q35108501-3059B445-29E1-4623-9BED-B3CEF48E9F10Q35651714-B624B4FF-B1CC-49AD-9C23-0D030B514D51Q35925259-4E919682-CC82-43C8-A149-E79EBED5F5B1Q36036263-F6592863-9F75-43D5-A2F2-7A434385AD27Q37019311-E4286882-222B-4A56-BC5D-A3507547F28AQ37327786-466F94BA-8FE4-46FD-970E-C00735B6972AQ37515517-B40B44D1-1CE0-4B4E-A25E-BA1B224F25A7Q37671806-2BE4445E-4CEA-4BD4-B769-744E4FFA49D0Q37701625-416E7511-0BF9-47C6-8FDA-6388A0136B53Q37961859-EF89D8E5-FBE9-4511-B5E7-A4C89F3FCF82Q38163846-21B17747-7FFD-4826-8193-DD87B4D70550Q39247434-FC7EDCAF-0925-466C-BD05-E1E721D33914Q42837099-F47E57A5-D8AC-483D-802B-6029A29C8A7AQ51776651-E2240C4C-BFBB-4594-8FB4-0CFC5340C7A2Q53131124-27BE651F-6C33-47CC-B69F-99CDFD1F57DB
P2860
Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Progressive chromatin repressi ...... advanced myeloid malignancies.
@en
Progressive chromatin repressi ...... advanced myeloid malignancies.
@nl
type
label
Progressive chromatin repressi ...... advanced myeloid malignancies.
@en
Progressive chromatin repressi ...... advanced myeloid malignancies.
@nl
prefLabel
Progressive chromatin repressi ...... advanced myeloid malignancies.
@en
Progressive chromatin repressi ...... advanced myeloid malignancies.
@nl
P2093
P2860
P1433
P1476
Progressive chromatin repressi ...... advanced myeloid malignancies
@en
P2093
B Douglas Smith
Craig Hooker
Hetty E Carraway
Hsing-Chen Tsai
Hua-Ling Tsai
James G Herman
Jaroslaw P Maciejewski
Judith E Karp
Lukasz P Gondek
Michael A McDevitt
P2860
P304
P356
10.1158/0008-5472.CAN-09-1153
P407
P577
2009-10-13T00:00:00Z